Corcept Therapeutics Announces Third Quarter Results and Corporate and Development Update
November 10, 2010 08:00 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - November 10, 2010) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery and development of drugs for the treatment...
Steven Lo Joins Corcept as Vice President of Commercial Operations
September 16, 2010 05:00 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - September 16, 2010) - Corcept Therapeutics Incorporated ("Corcept") (NASDAQ: CORT), a pharmaceutical company engaged in the discovery and development of drugs for...
Corcept Therapeutics Announces Second Quarter Results and Corporate and Development Update
August 12, 2010 08:00 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - August 12, 2010) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery and development of drugs for the treatment of...
Corcept Therapeutics Completes Enrollment in Phase 3 Cushing's Syndrome Study -- Data Announcement Anticipated by Year End
July 01, 2010 08:00 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - July 1, 2010) - Corcept Therapeutics Incorporated ("Corcept") (NASDAQ: CORT), a pharmaceutical company engaged in the discovery and development of drugs for the...
Corcept Therapeutics Announces Pricing of $15 Million Underwritten Public Offering of Common Stock
June 25, 2010 09:36 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - June 25, 2010) - Corcept Therapeutics Incorporated ("Corcept") (NASDAQ: CORT), a pharmaceutical company engaged in the discovery and development of drugs for the...
Corcept Therapeutics Nears Completion of Enrollment in Phase 3 Cushing's Syndrome Study -- Data Announcement Anticipated by Year End
June 25, 2010 06:00 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - June 25, 2010) - Corcept Therapeutics Incorporated ("Corcept") (NASDAQ: CORT), a pharmaceutical company engaged in the discovery and development of drugs for the...
Corcept Therapeutics Announces First Quarter Results and Update on Development Programs
May 11, 2010 09:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - May 11, 2010) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery and development of drugs for the treatment of...
Corcept Therapeutics Updates Cushing's Syndrome Development and Recent Financing
May 03, 2010 09:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - May 3, 2010) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery and development of drugs for the treatment of...
Corcept Therapeutics Announces Exercise of Existing Warrants and Private Placement of Warrants
April 22, 2010 09:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - April 22, 2010) - Corcept Therapeutics Incorporated ("Corcept") (NASDAQ: CORT), a pharmaceutical company engaged in the discovery and development of drugs for the...
Corcept Therapeutics Announces Fourth Quarter and Full Year 2009 Results and Update on Development Programs
March 25, 2010 09:05 ET
|
Corcept Therapeutics
MENLO PARK, CA--(Marketwire - March 25, 2010) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery and development of
drugs for the treatment of...